GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OraSure Technologies Inc (FRA:EP3) » Definitions » EV-to-Revenue

OraSure Technologies (FRA:EP3) EV-to-Revenue : 0.35 (As of May. 26, 2024)


View and export this data going back to . Start your Free Trial

What is OraSure Technologies EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, OraSure Technologies's enterprise value is €99.8 Mil. OraSure Technologies's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €281.8 Mil. Therefore, OraSure Technologies's EV-to-Revenue for today is 0.35.

The historical rank and industry rank for OraSure Technologies's EV-to-Revenue or its related term are showing as below:

FRA:EP3' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.34   Med: 2.58   Max: 8.69
Current: 0.35

During the past 13 years, the highest EV-to-Revenue of OraSure Technologies was 8.69. The lowest was 0.34. And the median was 2.58.

FRA:EP3's EV-to-Revenue is ranked better than
93.38% of 831 companies
in the Medical Devices & Instruments industry
Industry Median: 3.24 vs FRA:EP3: 0.35

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), OraSure Technologies's stock price is €4.52. OraSure Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €3.80. Therefore, OraSure Technologies's PS Ratio for today is 1.19.


OraSure Technologies EV-to-Revenue Historical Data

The historical data trend for OraSure Technologies's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OraSure Technologies EV-to-Revenue Chart

OraSure Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.24 3.24 2.08 0.65 0.80

OraSure Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.41 0.50 0.80 0.67

Competitive Comparison of OraSure Technologies's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, OraSure Technologies's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OraSure Technologies's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where OraSure Technologies's EV-to-Revenue falls into.



OraSure Technologies EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

OraSure Technologies's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=99.813/281.814
=0.35

OraSure Technologies's current Enterprise Value is €99.8 Mil.
OraSure Technologies's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €281.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OraSure Technologies  (FRA:EP3) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

OraSure Technologies's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4.52/3.801
=1.19

OraSure Technologies's share price for today is €4.52.
OraSure Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.80.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OraSure Technologies EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of OraSure Technologies's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


OraSure Technologies (FRA:EP3) Business Description

Traded in Other Exchanges
Address
220 East First Street, Bethlehem, PA, USA, 18015
OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

OraSure Technologies (FRA:EP3) Headlines

No Headlines